Cargando…
Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of int...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640429/ https://www.ncbi.nlm.nih.gov/pubmed/36057902 http://dx.doi.org/10.1245/s10434-022-12356-9 |
_version_ | 1784825849167478784 |
---|---|
author | Siegenthaler, Franziska Johann, Silke Imboden, Sara Samartzis, Nicolas Ledermann-Liu, Haiyan Sarlos, Dimitri Eberhard, Markus Mueller, Michael D. |
author_facet | Siegenthaler, Franziska Johann, Silke Imboden, Sara Samartzis, Nicolas Ledermann-Liu, Haiyan Sarlos, Dimitri Eberhard, Markus Mueller, Michael D. |
author_sort | Siegenthaler, Franziska |
collection | PubMed |
description | BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of intrauterine manipulators in endometrial cancer. PATIENTS AND METHODS: This prospective multicenter study included patients with endometrial cancer undergoing laparoscopic staging surgery with the use of an intrauterine manipulator. We obtained three different sets of peritoneal washings: at the beginning of the surgical procedure, after the insertion of the intrauterine manipulator, and after the closure of the vaginal vault. The rate of positive peritoneal cytology conversion and its association with oncological outcomes was assessed. RESULTS: A total of 124 patients were included. Peritoneal cytology was negative in 98 (group 1) and positive in 26 (group 2) patients. In group 2, 16 patients presented with positive cytology at the beginning of the surgery (group 2a) and 10 patients had positive cytology conversion during the procedure (group 2b). Recurrence rate was significantly different among the study groups, amounting to 9.2%, 25.0%, and 60.0% for groups 1, 2a, and 2b, respectively (p < 0.001). Group 1 showed the best recurrence-free and overall survival, followed by group 2a, while patients in group 2b had the worst oncological outcomes (p = 0.002 and p = 0.053, respectively). Peritoneal cytology was an independent predictor of recurrence and death on multivariable analysis. CONCLUSION: A total of 8.1% of patients with endometrial cancer undergoing minimally invasive surgery with intrauterine manipulation showed positive peritoneal cytology conversion associated with significantly worse oncological outcome. |
format | Online Article Text |
id | pubmed-9640429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96404292022-11-15 Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer Siegenthaler, Franziska Johann, Silke Imboden, Sara Samartzis, Nicolas Ledermann-Liu, Haiyan Sarlos, Dimitri Eberhard, Markus Mueller, Michael D. Ann Surg Oncol Gynecologic Oncology BACKGROUND: Minimally invasive surgery is the standard approach in early-stage endometrial cancer according to evidence showing no compromise in oncological outcomes, but lower morbidity compared with open surgery. However, there are limited data available on the oncological safety of the use of intrauterine manipulators in endometrial cancer. PATIENTS AND METHODS: This prospective multicenter study included patients with endometrial cancer undergoing laparoscopic staging surgery with the use of an intrauterine manipulator. We obtained three different sets of peritoneal washings: at the beginning of the surgical procedure, after the insertion of the intrauterine manipulator, and after the closure of the vaginal vault. The rate of positive peritoneal cytology conversion and its association with oncological outcomes was assessed. RESULTS: A total of 124 patients were included. Peritoneal cytology was negative in 98 (group 1) and positive in 26 (group 2) patients. In group 2, 16 patients presented with positive cytology at the beginning of the surgery (group 2a) and 10 patients had positive cytology conversion during the procedure (group 2b). Recurrence rate was significantly different among the study groups, amounting to 9.2%, 25.0%, and 60.0% for groups 1, 2a, and 2b, respectively (p < 0.001). Group 1 showed the best recurrence-free and overall survival, followed by group 2a, while patients in group 2b had the worst oncological outcomes (p = 0.002 and p = 0.053, respectively). Peritoneal cytology was an independent predictor of recurrence and death on multivariable analysis. CONCLUSION: A total of 8.1% of patients with endometrial cancer undergoing minimally invasive surgery with intrauterine manipulation showed positive peritoneal cytology conversion associated with significantly worse oncological outcome. Springer International Publishing 2022-09-04 2022 /pmc/articles/PMC9640429/ /pubmed/36057902 http://dx.doi.org/10.1245/s10434-022-12356-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Gynecologic Oncology Siegenthaler, Franziska Johann, Silke Imboden, Sara Samartzis, Nicolas Ledermann-Liu, Haiyan Sarlos, Dimitri Eberhard, Markus Mueller, Michael D. Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title | Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title_full | Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title_fullStr | Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title_full_unstemmed | Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title_short | Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer |
title_sort | prospective multicenter trial assessing the impact of positive peritoneal cytology conversion on oncological outcome in patients with endometrial cancer undergoing minimally invasive surgery with the use of an intrauterine manipulator: positive peritoneal cytology conversion and its association with oncological outcome in endometrial cancer |
topic | Gynecologic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640429/ https://www.ncbi.nlm.nih.gov/pubmed/36057902 http://dx.doi.org/10.1245/s10434-022-12356-9 |
work_keys_str_mv | AT siegenthalerfranziska prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT johannsilke prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT imbodensara prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT samartzisnicolas prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT ledermannliuhaiyan prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT sarlosdimitri prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT eberhardmarkus prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat AT muellermichaeld prospectivemulticentertrialassessingtheimpactofpositiveperitonealcytologyconversionononcologicaloutcomeinpatientswithendometrialcancerundergoingminimallyinvasivesurgerywiththeuseofanintrauterinemanipulatorpositiveperitonealcytologyconversionanditsassociat |